Rights and permissions
About this article
Cite this article
Cyclosporin in resistant nephrotic syndrome is of most benefit to those partially responsive to steroid therapy. Inpharma Wkly. 722, 16 (1990). https://doi.org/10.2165/00128413-199007220-00039
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007220-00039